Pseudoxanthoma elasticum-like papillary dermal elastolysis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:228293L98.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Pseudoxanthoma elasticum-like papillary dermal elastolysis (PXE-like papillary dermal elastolysis), also known as papillary dermal elastolysis or fibroelastolytic papulosis, is a rare acquired skin disorder that primarily affects elderly women. It is characterized by the appearance of small, yellowish-white, non-follicular papules that may coalesce into cobblestone-like plaques, typically distributed on the neck, axillae, and other flexural areas. The clinical appearance closely mimics pseudoxanthoma elasticum (PXE), but the two conditions are distinct. Unlike PXE, this disorder does not involve systemic complications such as ocular angioid streaks or cardiovascular calcification. Histologically, the condition is defined by a selective loss or fragmentation of elastic fibers in the papillary dermis, without the calcification of elastic fibers that is characteristic of true PXE. The mid and deep dermal elastic fibers are typically preserved. The pathogenesis remains poorly understood, and no specific genetic mutation has been identified; the condition is considered acquired and sporadic rather than inherited. There is no established curative treatment for PXE-like papillary dermal elastolysis. The condition is generally benign and primarily of cosmetic concern. Management is largely supportive and may include reassurance and differentiation from true PXE to avoid unnecessary systemic investigations. The prognosis is favorable as the disease does not progress to involve other organ systems. Due to its rarity, awareness among clinicians is important to prevent misdiagnosis as PXE or other elastolytic conditions.

Also known as:

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Late onset

Begins later in life, typically after age 50

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Pseudoxanthoma elasticum-like papillary dermal elastolysis.

View clinical trials →

No actively recruiting trials found for Pseudoxanthoma elasticum-like papillary dermal elastolysis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Pseudoxanthoma elasticum-like papillary dermal elastolysis community →

No specialists are currently listed for Pseudoxanthoma elasticum-like papillary dermal elastolysis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Pseudoxanthoma elasticum-like papillary dermal elastolysis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Pseudoxanthoma elasticum-like papillary dermal elastolysisForum →

No community posts yet. Be the first to share your experience with Pseudoxanthoma elasticum-like papillary dermal elastolysis.

Start the conversation →

Latest news about Pseudoxanthoma elasticum-like papillary dermal elastolysis

No recent news articles for Pseudoxanthoma elasticum-like papillary dermal elastolysis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Pseudoxanthoma elasticum-like papillary dermal elastolysis

What is Pseudoxanthoma elasticum-like papillary dermal elastolysis?

Pseudoxanthoma elasticum-like papillary dermal elastolysis (PXE-like papillary dermal elastolysis), also known as papillary dermal elastolysis or fibroelastolytic papulosis, is a rare acquired skin disorder that primarily affects elderly women. It is characterized by the appearance of small, yellowish-white, non-follicular papules that may coalesce into cobblestone-like plaques, typically distributed on the neck, axillae, and other flexural areas. The clinical appearance closely mimics pseudoxanthoma elasticum (PXE), but the two conditions are distinct. Unlike PXE, this disorder does not invol

How is Pseudoxanthoma elasticum-like papillary dermal elastolysis inherited?

Pseudoxanthoma elasticum-like papillary dermal elastolysis follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Pseudoxanthoma elasticum-like papillary dermal elastolysis typically begin?

Typical onset of Pseudoxanthoma elasticum-like papillary dermal elastolysis is late onset. Age of onset can vary across affected individuals.